GoldBamboo.com - Knowledge is strong medicine
  

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection. - Article


  Not Signed In - Sign In / Register






Salmonella typhi Infection


Clinical Trial: Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection.

This study is currently recruiting patients.
Verified by GlobeImmune July 2005

Sponsored by: GlobeImmune
Information provided by: GlobeImmune
ClinicalTrials.gov Identifier: NCT00124215

Purpose

The GI-5005 therapeutic vaccine or placebo will be injected under the skin of HCV subjects. Patients will be monitored for safety, immune responses and any therapeutic benefits related to the injections.
Condition Intervention Phase
Hepatitis C Infection
 Vaccine: GI-5005
Phase I

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study

Official Title: A Phase 1 Double-Blind, Placebo Controlled, Dose-Escalation, Multi-Center Therapeutic Trial of the Safety, Immunogenicity, and Efficacy of GI-5005; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing a Hepatitis C Virus NS3-Core Fusion Protein, in Patients with Chronic Hepatitis C Infection.

Further Study Details: 

Expected Total Enrollment:  48

Study start: June 2005

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria: Patients with chronic hepatitis C virus infection including treatment naive subjects as well as subjects who are partial responders and relapsers to prior interferon therapy, >18 years of age, negative skin test for hypersensitivity to saccharomyces cerevisiae.

Exclusion Criteria: non-responders to previous interferon treatments, cirrhosis, HCV treatment within 3 months, hepatitis B infection, HIV infection.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00124215

John Ferraro      720-859-4134 

California
      Huntington Medical Research Institutes, Pasadena,  California,  91105,  United States; Recruiting
Ruth Co  626-397-5825 
Myron Tong, M.D.,  Principal Investigator

Colorado
      University of Colorado Health Sciences Center, Denver,  Colorado,  80262,  United States; Recruiting
Jennifer DeSanto  303-315-1128 
Gregory Everson, M.D.,  Principal Investigator

Florida
      University of Miami, Miami,  Florida,  33136,  United States; Recruiting
Angelique Brown  305-243-2184 
Eugene Schiff, M.D.,  Principal Investigator

Illinois
      University of Chicago, Chicago,  Illinois,  60637,  United States; Recruiting
Katie Wherity  773-702-4477 
Helen Te, M.D.,  Principal Investigator
Donald Jensen, M.D.,  Sub-Investigator

New York
      Weill Medical College of Cornell University, New York City,  New York,  10021,  United States; Recruiting
Mary Ahern  212-746-2115 
Ira Jacobson, M.D.,  Principal Investigator

More Information

Study ID Numbers:  GI-5005-01
Last Updated:  August 1, 2005
Record first received:  July 26, 2005
ClinicalTrials.gov Identifier:  NCT00124215
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-02


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Salmonella typhi Infection.

October 7, 2008



Page Updated: November 22, 2004
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.